Molecular modelling of members of the P4502A subfamily: application to studies of enzyme specificity

References

• Cohen A. J. Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. Food and Chemical Toxicology 1979; 17: 277–289
   Web of Science ®Google Scholar
• Ding S., Lake B. G., Friedberg T., Wolf C. R. Expression and alternative splicing of cytochrome P450, CYP2A7. Biochemical Journal 1994, (in press)
   PubMed Web of Science ®Google Scholar
• Edwards R. J., Murray B. P., Murray S., Schulz T., Neubert D., Gant T. W., Thorgeirsson S. S., Boobis A. R., Davies D. S. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and humans. Carcinogenesis 1994; 15: 829–836
   PubMed Web of Science ®Google Scholar
• Edwards R. J., Murray B. P., Singleton A. M., Murray S., Davies D. S., Boobis A. P. Identification of the epitope of an anti-peptide antibody which binds to CYP1A2 in many species including man. Biochemical Pharmacology 1993; 46: 213–220
   PubMed Web of Science ®Google Scholar
• Forrester L. M., Henderson C. J., Glancey M. J., Back D. J., Park B. K., Ball S. E., Kitteringham N. R., McLaren A. W., Miles J. S., Skett P., Wolf C. R. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochemical Journal 1992; 281: 359–368
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology 1991; 4: 391–407
   PubMed Web of Science ®Google Scholar
• Kaighen M., Williams R. T. The metabolism of [3-14C]coumarin. Journal of Medicinal Chemistry 1961; 3: 25–43
   Web of Science ®Google Scholar
• Korzekwa K. R., Jones J. P. Predicting the cytochrome P450 mediated metabolism of xenobiotics. Pharmacogenetics 1993; 3: 1–18
   PubMedGoogle Scholar
• Lake B. G., Gaudin H., Price R. J., Walters D. G. Metabolism of [3-14C]coumarin to polar and covalently bound products by hepatic microsomes from the rat, Syrian hamster, gerbil and humans. Food and Chemical Toxicology 1992; 30: 105–115
   PubMed Web of Science ®Google Scholar
• Lake B. G., Walters D. G., Gangolli S. D. Comparison of the metabolism and disposition of [3-14C]coumarin in the rat and marmoset (Callithrix jacchus). Toxicology Letters 1989; 45: 299–306
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Three dimensional models of human and other mammalian microsomal P450s constructed from an alignment with CYP102 (P450BM3). Xenobiotica 1995a; 25, (in press)
   Web of Science ®Google Scholar
• Lewis D. F. V. Molecular modelling of mammalian cytochrome P450. Cytochromes P450: Metabolic and Toxicological Aspects, C. Ioannides. CRC Press, Boca Raton 1995b, (in press)
   Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Validation of a novel molecular orbital approach (COMPACT) for the prospective safety evaluation of chemicals, by comparison with rodent carcinogenicity and salmonella mutagenicity data evaluated by the U.S. NCI/NTP. Mutation Research 1993; 291: 61–77
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Moereels H. The sequence homologies of cytochromes P-450 and active site geometries. Journal of Computer-Aided Molecular Design 1992; 6: 235–252
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Moereels H., Lake B. G., Ioannides C., Parke D. V. Molecular modelling of enzymes and receptors involved in carcinogenesis: QSARs and COMPACT-3D. Drug Metabolism Reviews 1994; 26: 261–285
   PubMed Web of Science ®Google Scholar
• Lindberg R. L. P., Negishi M. Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue. Nature 1989; 339: 632–634
   PubMed Web of Science ®Google Scholar
• Miles J. S., McLaren A. W., Forrester L. M., Glancey M. J., Lang M. A., Wolf C. R. Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochemical Journal 1990; 267: 365–371
   PubMed Web of Science ®Google Scholar
• Murray B. P., Edwards R. J., Murray S., Singleton A. M., Davies D. S., Boobis A. R. Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhlP. Carcinogenesis 1993; 14: 585–592
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Gonzalez F. J. P450 genes: structure, evolution and regulation. Annual Review of Biochemistry 1987; 56: 945–993
   PubMed Web of Science ®Google Scholar
• Negishi M., Lindberg R., Burkhart B., Ichikawa T., Honkakoski P., Lang M. Mouse steroid 15α-hydroxylase gene family: identification of Type II P-45015α as coumarin 7-hydroxylase. Biochemistry 1989; 28: 4169–4172
   PubMed Web of Science ®Google Scholar
• Nelson D. R., Kamataki T., Waxman D. J., Guengerich F. P., Estabrook R. W., Feyereisen R., Gonzalez F. J., Coon M. J., Gunsalus I. C., Gotoh O., Okuda K., Nebert D. W. The P-450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and Cell Biology 1993; 12: 1–51
   PubMed Web of Science ®Google Scholar
• Nelson D. R., Strobel H. W. Secondary structure prediction of 52 membrane-bound cytochromes P-450 shows a strong similarity with P450cam. Biochemistry 1989; 28: 656–660
   PubMed Web of Science ®Google Scholar
• Pearce R., Greenway D., Parkinson A. Species differences and interindividual variation in liver microsomal P4502A enzymes: effect of coumarin, dicumarol and testosterone oxidation. Archives of Biochemistry and Biophysics 1992; 298: 211–225
   PubMed Web of Science ®Google Scholar
• Poulos T. L. Reversing enzyme specificity. Nature 1989; 339: 580–581
   PubMed Web of Science ®Google Scholar
• Poulos T. L., Finzel B. C., Gunsalus I. C., Wagner G. C., Kraut J. The 2.6-Å crystal structure of Pseudomonas putida cytochrome P-450. Journal of Biological Chemistry 1985; 260: 16122–16130
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Raunio H., Rautio A., Mäenpää J., Lang M. A. Coumarin 7-hydroxylase: characteristics and regulation in mouse and man. Journal of the Irish Colleges of Physicians and Surgeons 1993; 22(suppl. 1)24–28
   Google Scholar
• Ravichandran K. G., Boddupalli S. S., Hasemann C. A., Peterson J. A., Deisenhofer J. Crystal structure of hemoprotein domain of P450 BM-3, a prototype for microsomal P450s. Science 1993; 261: 731–736
   PubMed Web of Science ®Google Scholar
• Squires E. J., Negishi M. Tissue-specific regulation of cytochrome P-450 dependent testosterone 15α-hydroxylase. Canadian Journal of Physiology and Pharmacology 1990; 68: 769–776
   PubMed Web of Science ®Google Scholar
• Steensma A., Beamand J. A., Walters D. G., Price R. J., Lake B. G. Metabolism of coumarin and 7-ethoxycoumarin by rat, mouse, guinea pig, Cynomolgus monkey and human precision-cut liver slices. Xenobiotica 1994; 24: 893–907
   PubMed Web of Science ®Google Scholar
• Yamano S., Tatsuno J., Gonzalez F. J. The CYP2A3 gene product catalyses coumarin 7-hydroxylation in human liver microsomes. Biochemistry 1990; 29: 1322–1329
   PubMed Web of Science ®Google Scholar